CN102925580A - Notch1基因突变的快速检测方法 - Google Patents
Notch1基因突变的快速检测方法 Download PDFInfo
- Publication number
- CN102925580A CN102925580A CN2012104616583A CN201210461658A CN102925580A CN 102925580 A CN102925580 A CN 102925580A CN 2012104616583 A CN2012104616583 A CN 2012104616583A CN 201210461658 A CN201210461658 A CN 201210461658A CN 102925580 A CN102925580 A CN 102925580A
- Authority
- CN
- China
- Prior art keywords
- wild
- mutant
- notch1
- type
- template
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 10
- 101150079595 Notch1 gene Proteins 0.000 title claims abstract description 6
- 206010064571 Gene mutation Diseases 0.000 title claims abstract description 4
- 239000012634 fragment Substances 0.000 claims abstract description 56
- 238000000034 method Methods 0.000 claims abstract description 40
- 238000002844 melting Methods 0.000 claims abstract description 23
- 230000008018 melting Effects 0.000 claims abstract description 23
- 230000000869 mutational effect Effects 0.000 claims abstract description 19
- 102000001759 Notch1 Receptor Human genes 0.000 claims abstract description 12
- 108010029755 Notch1 Receptor Proteins 0.000 claims abstract description 12
- 230000003321 amplification Effects 0.000 claims abstract description 6
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 6
- 230000008859 change Effects 0.000 claims description 39
- 239000013641 positive control Substances 0.000 claims description 17
- 230000004304 visual acuity Effects 0.000 claims description 16
- 108020004414 DNA Proteins 0.000 claims description 13
- 238000010790 dilution Methods 0.000 claims description 12
- 239000012895 dilution Substances 0.000 claims description 12
- 108090000623 proteins and genes Proteins 0.000 claims description 10
- 238000013461 design Methods 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 238000011880 melting curve analysis Methods 0.000 claims description 7
- 238000000137 annealing Methods 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 230000004087 circulation Effects 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 238000012360 testing method Methods 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 5
- 238000012408 PCR amplification Methods 0.000 claims description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 4
- 238000002474 experimental method Methods 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 239000013642 negative control Substances 0.000 claims description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 3
- 239000003146 anticoagulant agent Substances 0.000 claims description 3
- 229940127219 anticoagulant drug Drugs 0.000 claims description 3
- 230000010100 anticoagulation Effects 0.000 claims description 3
- 238000003384 imaging method Methods 0.000 claims description 3
- 239000003471 mutagenic agent Substances 0.000 claims description 3
- 210000005259 peripheral blood Anatomy 0.000 claims description 3
- 239000011886 peripheral blood Substances 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 3
- 238000007400 DNA extraction Methods 0.000 claims description 2
- 238000003752 polymerase chain reaction Methods 0.000 abstract description 28
- 230000008901 benefit Effects 0.000 abstract description 5
- 230000004907 flux Effects 0.000 abstract description 3
- 230000035945 sensitivity Effects 0.000 abstract description 3
- 239000000047 product Substances 0.000 description 17
- 108010070047 Notch Receptors Proteins 0.000 description 9
- 206010028980 Neoplasm Diseases 0.000 description 8
- 108700037638 Neurogenic locus notch homolog protein 1 Proteins 0.000 description 8
- 102100023181 Neurogenic locus notch homolog protein 1 Human genes 0.000 description 7
- 102000005650 Notch Receptors Human genes 0.000 description 7
- 239000000975 dye Substances 0.000 description 6
- 238000011529 RT qPCR Methods 0.000 description 4
- 238000013459 approach Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 206010059866 Drug resistance Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000007705 epithelial mesenchymal transition Effects 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 108091070501 miRNA Proteins 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 1
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 1
- 108010027344 Basic Helix-Loop-Helix Transcription Factors Proteins 0.000 description 1
- 102000018720 Basic Helix-Loop-Helix Transcription Factors Human genes 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 102000005720 Glutathione transferase Human genes 0.000 description 1
- 108010070675 Glutathione transferase Proteins 0.000 description 1
- 208000028018 Lymphocytic leukaemia Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108700011259 MicroRNAs Proteins 0.000 description 1
- 108010077850 Nuclear Localization Signals Proteins 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
- 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 description 1
- 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 description 1
- 108700005075 Regulator Genes Proteins 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229940044683 chemotherapy drug Drugs 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 101150030367 cls gene Proteins 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000008175 fetal development Effects 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000007499 fusion processing Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 229940000351 hemocyte Drugs 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 208000003747 lymphoid leukemia Diseases 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
Images
Abstract
Description
MasterMix组成: | (1x) | (5x) |
25mMMgCl2 | 1.2μl | 6μl |
2μM NOT1F primer | 1μl | 5μl |
2μM NOT1R primer | 1μl | 5μl |
H2O | 1.3μl | 6.5μl |
Σ= | 4.5μl | 22.5μl |
引物名称 | 引物序列(5’-3’) |
NOT1F | GAGCATGTACCCGAGAGGC |
NOT1R | GAAGATCATCTGCTGGCCGT |
NOT6MF | ACGTGGTCTCCAAGCGTGAC |
NOT6MR | GTCACGCTTGGAGACCACGT |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210461658.3A CN102925580B (zh) | 2012-11-16 | 2012-11-16 | Notch1基因突变的快速检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210461658.3A CN102925580B (zh) | 2012-11-16 | 2012-11-16 | Notch1基因突变的快速检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102925580A true CN102925580A (zh) | 2013-02-13 |
CN102925580B CN102925580B (zh) | 2014-12-17 |
Family
ID=47640503
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210461658.3A Expired - Fee Related CN102925580B (zh) | 2012-11-16 | 2012-11-16 | Notch1基因突变的快速检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102925580B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103409429A (zh) * | 2013-07-29 | 2013-11-27 | 新疆维吾尔自治区畜牧科学院中国-澳大利亚绵羊育种研究中心 | 一种克隆绵羊Notch1基因胞内结构域NICD的方法 |
CN104498611A (zh) * | 2014-12-22 | 2015-04-08 | 西北农林科技大学 | 检测黄牛 Notch1 基因 SNP 位点的 RFLP 方法及试剂盒 |
CN106755425A (zh) * | 2016-12-26 | 2017-05-31 | 国风 | 一种慢性淋巴细胞白血病患者notch1基因突变检测组合物 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100821457B1 (ko) * | 2006-11-24 | 2008-04-11 | (주)아모레퍼시픽 | Idh3a 프로모터 및 루시퍼라제 함유 벡터로형질전환된 세포주, 및 그를 이용한 비만억제 후보물질검색방법 |
CN102732633A (zh) * | 2012-07-06 | 2012-10-17 | 广州好芝生物科技有限公司 | 人idh基因突变的检测引物和试剂盒 |
-
2012
- 2012-11-16 CN CN201210461658.3A patent/CN102925580B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100821457B1 (ko) * | 2006-11-24 | 2008-04-11 | (주)아모레퍼시픽 | Idh3a 프로모터 및 루시퍼라제 함유 벡터로형질전환된 세포주, 및 그를 이용한 비만억제 후보물질검색방법 |
CN102732633A (zh) * | 2012-07-06 | 2012-10-17 | 广州好芝生物科技有限公司 | 人idh基因突变的检测引物和试剂盒 |
Non-Patent Citations (2)
Title |
---|
《Nature Medicine》 20061217 Tomas Vilimas et al. Targeting the NF-B signaling pathway in Notch1-induced T-cell leukemia 70 - 77 第13卷, 第1期 * |
沈薇等: "高分辨率熔解曲线及其在分子诊断中的应用", 《检验医学》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103409429A (zh) * | 2013-07-29 | 2013-11-27 | 新疆维吾尔自治区畜牧科学院中国-澳大利亚绵羊育种研究中心 | 一种克隆绵羊Notch1基因胞内结构域NICD的方法 |
CN104498611A (zh) * | 2014-12-22 | 2015-04-08 | 西北农林科技大学 | 检测黄牛 Notch1 基因 SNP 位点的 RFLP 方法及试剂盒 |
CN106755425A (zh) * | 2016-12-26 | 2017-05-31 | 国风 | 一种慢性淋巴细胞白血病患者notch1基因突变检测组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN102925580B (zh) | 2014-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20200056244A1 (en) | Methods of treating a subject with a high gleason score prostate cancer | |
CN104946739B (zh) | Egfr基因突变检测试剂盒及其应用 | |
CN104818320A (zh) | 一次性检测肺癌多重基因的引物、探针、检测体系和试剂盒 | |
CN104818318A (zh) | 一次性检测肺癌多重基因的引物、探针、检测体系和试剂盒 | |
CN107312770A (zh) | 一种用于高通量测序检测的肿瘤brca1/2基因变异文库的构建方法及其应用 | |
CN103525901B (zh) | Mek1基因突变的快速检测方法 | |
WO2023024508A1 (zh) | 基于全基因组分析的真核生物物种鉴定方法及应用 | |
CN109593847A (zh) | 检测微卫星nr24位点稳定性的引物对、试剂盒及方法 | |
CN102925580B (zh) | Notch1基因突变的快速检测方法 | |
CN104073569A (zh) | 用于诊断手足口病极重症的分子标记物及其检测方法与试剂盒 | |
CN101921864A (zh) | 一种肝癌外周血基因诊断模型及诊断试剂盒 | |
CN107177676B (zh) | 长链非编码rna nonhsat113026用于肾癌诊断分子标志物的用途 | |
CN107641649B (zh) | 检测微卫星nr27位点稳定性的引物对、试剂盒及方法 | |
CN103397080A (zh) | Pten基因突变的快速检测方法 | |
CN107022620A (zh) | N‑ras基因突变检测引物探针及其试剂盒 | |
CN103571959B (zh) | 用于检测基因位点突变的引物、探针、试剂盒 | |
US20170051332A1 (en) | Methods and compositions for detecting expression of target genes | |
CN105603117B (zh) | miR-3613用于区分肺鳞癌转移与非转移的miRNA标志物 | |
CN109554475A (zh) | 用于肺结节良恶性鉴别的基因突变/融合组合及试剂盒 | |
CN103436593B (zh) | p53基因突变的快速检测方法 | |
CN102925582B (zh) | β-Catenin基因突变的快速检测方法 | |
CN107029238B (zh) | Linc01094在诊治缺血性脑卒中的应用 | |
CN111440868A (zh) | 喉鳞癌分子标记物hsa_circ_0018169及其检测方法和应用 | |
CN101671728B (zh) | 一种检测癌胚抗原mRNA表达量的方法及专用试剂盒 | |
CN102925579B (zh) | Idh2基因突变的快速检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI SAIAN MEDICAL TEST INSTITUTE CO., LTD. Free format text: FORMER OWNER: SHANGHAI SAIAN BIOLOGICAL MEDICAL TECHNOLOGY CO., LTD. Effective date: 20141102 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200032 BAOSHAN, SHANGHAI TO: 201900 BAOSHAN, SHANGHAI |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20141102 Address after: 201900, Shanghai, Baoshan District, Shanghai Road, No. 1888, first floor Applicant after: SHANGHAI SHINE MEDICAL INSTITUTE Co.,Ltd. Address before: 200032 209D room, No. 668, Da Dao, Baoshan District, Shanghai Applicant before: SHANGHAI SHINES PHARMACEUTICAL CO.,LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PP01 | Preservation of patent right |
Effective date of registration: 20200407 Granted publication date: 20141217 |
|
PP01 | Preservation of patent right | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20230407 Granted publication date: 20141217 |
|
PD01 | Discharge of preservation of patent | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141217 |